WELLS FARGO & COMPANY/MN - SELECTA BIOSCIENCES INC ownership

SELECTA BIOSCIENCES INC's ticker is SELB and the CUSIP is 816212104. A total of 46 filers reported holding SELECTA BIOSCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SELECTA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$29,470
-42.7%
27,801
-39.4%
0.00%
Q2 2023$51,418
+2601.9%
45,909
+3253.5%
0.00%
Q1 2023$1,903
+115.3%
1,369
+75.1%
0.00%
Q4 2022$884
-11.6%
782
+2.8%
0.00%
Q3 2022$1,0000.0%761
-10.8%
0.00%
Q2 2022$1,000
-99.1%
853
-99.1%
0.00%
Q1 2022$113,000
-70.3%
91,887
-21.4%
0.00%
Q4 2021$381,000
-34.4%
116,910
-16.4%
0.00%
Q3 2021$581,000
+153.7%
139,810
+155.0%
0.00%
Q2 2021$229,000
+118.1%
54,827
+138.2%
0.00%
Q1 2021$105,000
-70.0%
23,022
-80.1%
0.00%
Q4 2020$350,000
-11.2%
115,574
-27.4%
0.00%
Q3 2020$394,000
+10.4%
159,186
+26.5%
0.00%
Q2 2020$357,000125,844
+66133.7%
0.00%
Q1 2020$0
-100.0%
190
-90.1%
0.00%
Q2 2019$4,000
-81.0%
1,914
-78.2%
0.00%
Q1 2019$21,000
-8.7%
8,789
-0.3%
0.00%
Q4 2018$23,000
-93.8%
8,814
-63.1%
0.00%
Q3 2018$372,000
+17.7%
23,897
+0.3%
0.00%
Q2 2018$316,000
+38.0%
23,826
+6.2%
0.00%
Q1 2018$229,000
-0.4%
22,433
-4.5%
0.00%
Q4 2017$230,000
+21.1%
23,491
+125.8%
0.00%
Q3 2017$190,000
+84.5%
10,405
+100.4%
0.00%
Q2 2017$103,000
+39.2%
5,192
+0.1%
0.00%
Q1 2017$74,000
-16.9%
5,1870.0%0.00%
Q4 2016$89,0005,1870.00%
Other shareholders
SELECTA BIOSCIENCES INC shareholders Q1 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,024,668$4,283,0001.71%
CM Management, LLC 400,000$1,672,0001.21%
Endurant Capital Management LP 926,935$3,875,0001.06%
Boxer Capital, LLC 3,284,072$13,727,0000.48%
IRONWOOD INVESTMENT MANAGEMENT LLC 192,043$803,0000.40%
Artal Group S.A. 4,000,000$16,720,0000.34%
BVF INC/IL 1,693,456$7,079,0000.26%
Cetera Advisors LLC 1,106,325$4,624,0000.11%
Virtus ETF Advisers LLC 44,648$187,0000.08%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,220,138$9,280,0000.06%
View complete list of SELECTA BIOSCIENCES INC shareholders